Literature DB >> 17151102

Absence or overexpression of the Varicella-Zoster Virus (VZV) ORF29 latency-associated protein impairs late gene expression and reduces VZV latency in a rodent model.

Jeffrey I Cohen1, Tammy Krogmann, Lesley Pesnicak, Mir A Ali.   

Abstract

Varicella-zoster virus (VZV) ORF29 encodes the viral single-stranded DNA binding protein and is expressed during latency in human ganglia. We constructed an ORF29 deletion mutant virus and showed that the virus could replicate only in cells expressing ORF29. An ORF29-repaired virus, in which ORF29 was driven by a cytomegalovirus promoter, grew to peak titers similar to those seen with the parental virus. The level of ORF29 protein in cells infected with the repaired virus was greater than that seen with parental virus. Infection of cells with either the ORF29 deletion or repaired virus resulted in similar levels of VZV immediate-early proteins but reduced levels of glycoprotein E compared to those observed with parental virus. Cotton rats infected with the ORF29 deletion mutant had a markedly reduced frequency of latent infection in dorsal root ganglia compared with those infected with parental virus (P < 0.00001). In contrast, infection of animals with the ORF29 deletion mutant resulted in a frequency of ganglionic infection at 3 days similar to that seen with the parental virus. Animals infected with the ORF29-repaired virus, which overexpresses ORF29, also had a reduced frequency of latent infection compared with those infected with parental virus (P = 0.0044). These studies indicate that regulation of ORF29 at appropriate levels is critical for VZV latency in a rodent model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151102      PMCID: PMC1797561          DOI: 10.1128/JVI.01220-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Identification and characterization of a varicella-zoster virus DNA-binding protein by using antisera directed against a predicted synthetic oligopeptide.

Authors:  P R Kinchington; G Inchauspe; J H Subak-Sharpe; F Robey; J Hay; W T Ruyechan
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Correct intranuclear localization of herpes simplex virus DNA polymerase requires the viral ICP8 DNA-binding protein.

Authors:  M Bush; D R Yager; M Gao; K Weisshart; A I Marcy; D M Coen; D M Knipe
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Varicella-zoster virus proteins in skin lesions: implications for a novel role of ORF29p in chickenpox.

Authors:  P W Annunziato; O Lungu; C Panagiotidis; J H Zhang; D N Silvers; A A Gershon; S J Silverstein
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model.

Authors:  C A Jones; T J Taylor; D M Knipe
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

5.  Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection.

Authors:  L H Nguyen; D M Knipe; R W Finberg
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  Varicella-zoster virus DNA polymerase and major DNA-binding protein genes have overlapping divergent promoters.

Authors:  J L Meier; S E Straus
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles.

Authors:  P R Kinchington; J K Hougland; A M Arvin; W T Ruyechan; J Hay
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.

Authors:  L A Morrison; D M Knipe
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Varicella-zoster virus transcription in human trigeminal ganglia.

Authors:  J L Meier; R P Holman; K D Croen; J E Smialek; S E Straus
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

10.  Selective cleavage of human DNA: RecA-assisted restriction endonuclease (RARE) cleavage.

Authors:  L J Ferrin; R D Camerini-Otero
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

View more
  17 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein.

Authors:  Mohamed I Khalil; Ann Arvin; Jeremy Jones; William T Ruyechan
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  The early UL31 gene of equine herpesvirus 1 encodes a single-stranded DNA-binding protein that has a nuclear localization signal sequence at the C-terminus.

Authors:  Seongman Kim; Byung Chul Ahn; Dennis J O'Callaghan; Seong Kee Kim
Journal:  Virology       Date:  2012-06-20       Impact factor: 3.616

4.  Varicella-zoster virus transcriptome in latently infected human ganglia.

Authors:  Maria A Nagel; Alexander Choe; Igor Traktinskiy; Robert Cordery-Cotter; Don Gilden; Randall J Cohrs
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

5.  A varicella-zoster virus mutant impaired for latency in rodents, but not impaired for replication in cell culture.

Authors:  Aruna P N Ambagala; Tammy Krogmann; Jing Qin; Lesley Pesnicak; Jeffrey I Cohen
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

Review 6.  The varicella-zoster virus genome.

Authors:  Jeffrey I Cohen
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 7.  VZV infection of keratinocytes: production of cell-free infectious virions in vivo.

Authors:  Michael D Gershon; Anne A Gershon
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 8.  Rodent models of varicella-zoster virus neurotropism.

Authors:  Jeffrey I Cohen
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

9.  The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection.

Authors:  Mir A Ali; Qingxue Li; Elizabeth R Fischer; Jeffrey I Cohen
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

10.  BAG3, a host cochaperone, facilitates varicella-zoster virus replication.

Authors:  Christos A Kyratsous; Saul J Silverstein
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.